Targeted Talks
By Targeted Oncology
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Targeted Oncology
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 2
Reviews: 0
Episodes: 99
Description
Targeted Talks is a podcast series from Targeted Oncology featuring one-on-one conversations with leading oncologists about the issues shaping cancer care today. Each episode explores the real-world challenges clinicians face alongside discussions of emerging research across tumor types. Whether unpacking new data, translating conference highlights into clinical context, or addressing the practical realities of oncology practice, Targeted Talks delivers timely, actionable conversations designed for today's oncology professionals.
For more visit: https://www.targetedonc.com/podcasts
For more visit: https://www.targetedonc.com/podcasts
| Episode | Date |
|---|---|
|
S8 Ep9: Dr Bazhenova on the Updated FDA Label for Taletrectinib in ROS1+ NSCLC
|
Oct 20, 2026 |
|
S8 Ep8: Lung Cancer in Hispanic and Latinx Patients: Risk Factors, Biomarkers, and Clinical Trial Access
|
Oct 13, 2026 |
|
S8 Ep7: Dr Jhaveri on the FDA Approval of Imlunestrant Plus Abemaciclib for ESR1-Mutated Breast Cancer
|
Oct 06, 2026 |
|
S8 Ep6: Dr Herzberg on the Expanding Toolkit in KRAS-Mutant Non–Small Cell Lung Cancer
|
Sep 29, 2026 |
|
S8 Ep5: ASTRO 2026 Preview: Dr Raj Singh on De-Escalation, Brain Metastases, and What's Next in Radiation Oncology
|
Sep 24, 2026 |
|
S8 Ep4: Bringing CAR T and Bispecifics to the Community
|
Sep 22, 2026 |
|
S8 Ep3: Rethinking HER2: A Pan-Cancer Look at IHC, ERBB2, and Tumor-Agnostic Testing
|
Sep 15, 2026 |
|
S8 Ep2: Radiation Oncology's Financial Squeeze with Dr Ryan Funk
|
Sep 08, 2026 |
|
S8 Ep1: Gynecologic Cancer Trends, Testing, and Treatment Advances Explained
|
Sep 01, 2026 |
|
S7 Ep19: AI in Oncology: Managing Information Overload for Trainees and Patients
|
Jul 15, 2026 |
|
S7 Ep18: Drowning in Data: How Oncologists Are Coping with Information Overload in the AI Era
|
Jul 01, 2026 |
|
S7 Ep17: Navigating the 505(b)(2) Pathway: Operational, Clinical, and Economic Strategies for Oncology Practices
|
Jun 17, 2026 |
|
S7 Ep16: ASCO 2026 Preview: Late-Breaking Abstracts Poised to Reshape the Treatment Landscape
|
May 20, 2026 |
|
S7 Ep15: Pediatric Blood Cancers: Building Better Outcomes Through Bold Science
|
May 06, 2026 |
|
S7 Ep14: Choosing Wisely in CLL: A Deep Dive Into Frontline Treatment
|
Apr 15, 2026 |
|
S7 Ep13: Leveraging AI, Social Media, and Virtual Care in the Information Age
|
Apr 01, 2026 |
|
S7 Ep12: Beyond Monotherapy: Mechanisms and Combination Strategies in NPM1-Mutant Acute Myeloid Leukemia
|
Mar 27, 2026 |
|
S7 Ep11: Treating Together: Navigating Treatment Decisions in Relapsed NPM1-Mutant AML: Practical Insights for Clinical Care
|
Mar 27, 2026 |
|
S7 Ep10: Beyond the Hospital Walls: Expanding Access to Complex Cancer Therapies
|
Mar 25, 2026 |
|
S7 Ep9: Test First, Treat Second: ASCO's Updated Approach to Driver Mutation–Negative NSCLC
|
Mar 11, 2026 |
|
S7 Ep8: Precision Hope: The New Frontier of AI-Driven Oncology
|
Mar 04, 2026 |
|
S7 Ep7: Community Oncology at a Crossroads: Navigating Policy, Progress, and Practice
|
Feb 18, 2026 |
|
S7 Ep6: Navigating the Future of CLL Care
|
Feb 04, 2026 |
|
S7 Ep5: Supporting Community Oncologists in a GU Research Era with Dr. Park, Dr. Garmezy, and Dr. Bupathi
|
Jan 21, 2026 |
|
S7 Ep4: Gut Health & Myeloma: How Bacteria May Predict Transplant Success With Pooja Phull, MD
|
Dec 15, 2025 |
|
S7 Ep3: Experts Delve Into Organ Preservation for Genitourinary Cancers
|
Oct 31, 2025 |
|
S7 Ep2: Navigating Modern Lung Cancer Treatment and Clinical Trial Access
|
Sep 29, 2025 |
|
S7 Ep1: Advancing Prostate Cancer Treatment With Shared Decision-Making
|
Jul 31, 2025 |
|
S6 Ep5: Predicting Palbociclib Outcomes in Breast Cancer Using Deep Learning
|
Apr 15, 2025 |
|
S6 Ep4: BMT CTN 1902 in Myeloma: Key Findings With Garfall
|
Mar 13, 2025 |
|
S6 Ep3: Exploring Innovations in Lymphoma Treatment With Russler-Germain
|
Feb 27, 2025 |
|
S6 Ep2: Behind the FDA Approval of Dato-DXd in HR+/HER2– Breast Cancer With Bardia
|
Feb 06, 2025 |
|
S6 Ep1: Juneja Explores AI’s Impact in Early Cancer Detection and Treatment
|
Jan 15, 2025 |
|
S5 Ep20: How AI Is Revolutionizing Oncology in Diagnosis, Treatment, and Research
|
Nov 14, 2024 |
|
S5 Ep19: Navigating ESR1 Mutations in HR-Positive Breast Cancer With Dr Wander
|
Oct 31, 2024 |
|
S5 Ep18: Turning Inspiration Into Innovation: Hazim’s Impact on Oncology
|
Oct 17, 2024 |
|
S5 Ep17: Kaklamani's Insights on EMERALD Trial and Elacestrant in Advanced Breast Cancer
|
Sep 26, 2024 |
|
S5 Ep16: Foran Goes Beyond the Basics of BPDCN
|
Sep 17, 2024 |
|
S5 Ep15: Tarantino Covers HER2-Low Breast Cancer and Antibody-Drug Conjugates
|
Aug 30, 2024 |
|
S5 Ep14: Breaking New Ground in Synovial Sarcoma: Choy on the FDA Approval of Afami-cel
|
Aug 15, 2024 |
|
S5 Ep13: Cancer Research Across Continents: Fujiwara’s Path From Japan to the US
|
Aug 01, 2024 |
|
S5 Ep12: Advancing Melanoma Treatment: Hamid on Lifileucel's Role
|
Jul 15, 2024 |
|
S5 Ep11: Transforming Prostate Cancer Care Through Personalized Medicine
|
Jul 01, 2024 |
|
S5 Ep10: Dhakal Reflects on the FDA Approval of Cilta-Cel for Earlier Lines of RRMM
|
Jun 14, 2024 |
|
S5 Ep9: Unlocking the Potential of Technology in Community Oncology
|
May 15, 2024 |
|
S5 Ep8: LaPelusa’s Journey in the Dynamic Field of GI Oncology
|
May 01, 2024 |
|
S5 Ep7: The Future of Breast Cancer Care: Blackwood on Personalized Approaches
|
Apr 15, 2024 |
|
S5 Ep6: Dizman’s Global Pursuit to Cancer Research and Understanding
|
Apr 01, 2024 |
|
S5 Ep5: FDA Approval Marks Amivantamab's Milestone in EGFR+ NSCLC
|
Mar 15, 2024 |
|
S5 Ep4: Enhancing Precision in Immunotherapy: CD8 PET-Avidity in RCC
|
Mar 01, 2024 |
|
S5 Ep3: Advancing Myeloma Treatment With Blood-Based MRD Testing
|
Feb 15, 2024 |
|
S5 Ep2: Beyond the First-Line: Economides on Advancing Therapies in RCC
|
Feb 01, 2024 |
|
S5 Ep1: A Deep Dive Into the Evolving Landscape of Prostate Cancer
|
Jan 15, 2024 |
|
S4 Ep20: Lisberg Discusses Dato-DXd's Role in Advanced Lung Cancer Care
|
Dec 15, 2023 |
|
S4 Ep19: Navigating the Landscape of Immunotherapy Toxicities
|
Nov 30, 2023 |
|
S4 Ep18: Behind the FDA Approval of Fruquintinib for Previously Treated mCRC
|
Nov 15, 2023 |
|
S4 Ep17: Bridging Science and Compassion in Cancer Care
|
Oct 31, 2023 |
|
S4 Ep16: Tailoring Treatments to Better Outcomes in Liver Cancer
|
Oct 13, 2023 |
|
S4 Ep15: Desai on Embracing Curiosity and Change in the Oncology Field
|
Sep 29, 2023 |
|
S4 Ep14: First Real-World Data on Second-Generation AR Inhibitor Use in nmCRPC
|
Sep 18, 2023 |
|
S4 Ep13: Strategies for Neoadjuvant NSCLC Treatment
|
Sep 01, 2023 |
|
S4 Ep12: Lessons from Real-World Cases of Small Cell Lung Cancer
|
Aug 15, 2023 |
|
S4 Ep11: Social Determinants of Health Impacting Oncology Today
|
Jul 31, 2023 |
|
S4 Ep10: Recommendations for Treating Central Nervous Systems Cancers
|
Jul 14, 2023 |
|
S4 Ep9: Mitigating Cardiotoxicity Resulting from Immune Checkpoint Inhibitor Therapy
|
Jun 30, 2023 |
|
S4 Ep8: Pushing Forward With Molecularly-Driven Precision Medicine in Endometrial Cancer
|
Jun 23, 2023 |
|
S4 Ep7: Exciting Activity in Chronic Lymphocytic Leukemia
|
May 31, 2023 |
|
S4 Ep6: Anticipating Novel Treatments for the RAI-Refractory DTC Armamentarium
|
May 15, 2023 |
|
S4 Ep5: Advancing the Treatment of Alveolar Soft Part Sarcoma
|
Apr 26, 2023 |
|
S4 Ep4: Understanding and Treating Mucosal Melanoma
|
Apr 14, 2023 |
|
S4 Ep3: Hitting New Targets in Metastatic Prostate Cancer
|
Mar 16, 2023 |
|
S4 Ep2: The Importance of Trastuzumab Deruxtecan in HER2+ Breast Cancer Treatment
|
Feb 28, 2023 |
|
S4 Ep1: Unpacking the Latest Research in Gastrointestinal Cancers
|
Feb 15, 2023 |
|
S3 Ep10: A More Precise Approach to Small Cell Lung Cancer Treatment
|
Nov 17, 2022 |
|
S3 Ep10: A More Precise Approach to Small Cell Lung Cancer Treatment
|
Nov 17, 2022 |
|
S3 Ep9: Special Episode: Managing Cardiotoxicity from ICI Therapy in Patients with Cancer
|
Oct 25, 2022 |
|
S3 Ep8: Treating HER2-Positive Beast Cancer in the Community Setting
|
Sep 16, 2022 |
|
S3 Ep7: The Evolution of Endometrial Cancer Treatment
|
Aug 15, 2022 |
|
S3 Ep6: Examining the Non-Hodgkin Lymphoma Treatment Paradigm
|
Jul 15, 2022 |
|
S3 Ep5: The Road to Improving Diffuse Large B-Cell Lymphoma Treatment
|
Jun 15, 2022 |
|
S3 Ep4: Better Strategies for the Treatment of High-Risk Chronic Lymphocytic Leukemia
|
May 17, 2022 |
|
S3 Ep3: Unpacking the New Recommendations for Early-Stage Breast Cancer Management
|
Apr 15, 2022 |
|
S3 Ep2: Advances and Pending Innovations in the Treatment of Sarcoma
|
Mar 16, 2022 |
|
S3 Ep1: A Look Inside the Toolbox for BRAF-Mutant Metastatic Melanoma
|
Feb 15, 2022 |
|
S2 Ep10: Treating Sarcoma With a Multidisciplinary Approach
|
Dec 15, 2021 |
|
S2 Ep9: Sequencing Therapy for Metastatic Castration-Resistant Prostate Cancer
|
Nov 17, 2021 |
|
S2 Ep8: New Targeted Therapies in Renal Cell Carcinoma
|
Sep 15, 2021 |
|
S2 Ep7: Recent Developments in Immunotherapy for Melanoma
|
Aug 16, 2021 |
|
S2 Ep6: Special Episode: Insight on Targeting Rare Genomic Alterations in Colorectal Cancer
|
Jul 15, 2021 |
|
S2 Ep5: Advancing the Treatment of Cervical and Endometrial Cancers
|
Jun 15, 2021 |
|
S2 Ep4: Special Episode: Oncology After COVID-19
|
May 14, 2021 |
|
S2 Ep3: Modern Strategies Improving Immunotherapy in Cancer
|
Apr 15, 2021 |
|
S2 Ep2: The Impact of the Gut Microbiome in Young Patients With Colorectal Cancer
|
Feb 15, 2021 |
|
S2 Ep1: Therapies on the Horizon in EGFR Exon 20–Positive Lung Cancer
|
Jan 15, 2021 |
|
S1 Ep5: COVID-19 Leaves Its Mark on Oncology Care
|
Dec 17, 2020 |
|
S1 Ep4: Prostate Cancer Sees Surge of PARP Inhibition Strategies
|
Oct 15, 2020 |
|
S1 Ep3: Breast Cancer Leans into the Decade of Antibody-Drug Conjugates, Experts Discuss
|
Sep 25, 2020 |
|
S1 Ep2: Precision Medicine Guiding Ovarian Cancer Treatment
|
Jul 15, 2020 |
|
S1 Ep1: Individualizing Immunotherapy in Non–Small Cell Lung Cancer
|
Jun 15, 2020 |